Vaccine design paper against COVID-19 protein gets retracted

AI Insight

This is a retraction notice from PLOS ONE Editors withdrawing a previously published article about epitope-based peptide vaccine design and novel compounds targeting the 3C-like protein of SARS-CoV-2. The retraction indicates that the original article has been formally withdrawn from the scientific record. No details about the specific reasons for retraction are provided in the notice itself.

Why it matters

Retractions are critical for maintaining scientific integrity by removing flawed or unreliable research from the literature. This retraction means researchers and vaccine developers should not rely on the findings from the withdrawn article when developing COVID-19 therapeutics or vaccines.